EDGAR Filing Documents for 0001104659-15-072063

Form 8-K - Current report:

SEC Accession No. 0001104659-15-072063

Filing Date

2015-10-22

Accepted

2015-10-22 08:05:51

Documents

Period of Report

2015-10-21

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-21514_18k.htm	8-K	28081
2	EX-99.1	a15-21514_1ex99d1.htm	EX-99.1	5648
3	EX-99.2	a15-21514_1ex99d2.htm	EX-99.2	2551
4	GRAPHIC	g215141moi001.gif	GRAPHIC	187338
5	GRAPHIC	g215141mmi001.jpg	GRAPHIC	4656
	Complete submission text file	0001104659-15-072063.txt		302198

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524

INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)